Development of curative therapies for ewing sarcomas by interdisciplinary cooperative groups in Europe

T. Bölling; G. Braun-Munzinger; S. Burdach; G. Calaminus; A. Craft; O. Delattre; M. C.L. Deley; U. Dirksen; B. Dockhorn-Dworniczak; J. Dunst; S. Engel; A. Faldum; B. Fröhlich; H. Gadner; U. Göbel; G. Gosheger; J. Hardes; D. S. Hawkins; L. Hjorth; C. Hoffmann; H. Kovar; J. Kruseova; R. Ladenstein; I. Leuschner; I. J. Lewis; O. Oberlin; M. Paulussen; J. Potratz; A. Ranft; C. Rössig; C. Rübe; R. Sauer; O. Schober; A. Schuck; B. Timmermann; F. Tirode; H. Van Den Berg; F. Van Valen; V. Vieth; N. Willich; W. Winkelmann; J. Whelan; R. B. Womer

doi:10.1055/s-0035-1545263

Development of curative therapies for ewing sarcomas by interdisciplinary cooperative groups in Europe

T. Bölling
, G. Braun-Munzinger
, S. Burdach
, G. Calaminus
, A. Craft
, O. Delattre
, M. C.L. Deley
, U. Dirksen
, B. Dockhorn-Dworniczak
, J. Dunst
, S. Engel
, A. Faldum
, B. Fröhlich
, H. Gadner
, U. Göbel
, G. Gosheger
, J. Hardes
, D. S. Hawkins
, L. Hjorth
, C. Hoffmann

H. Kovar, J. Kruseova, R. Ladenstein, I. Leuschner, I. J. Lewis, O. Oberlin, M. Paulussen, J. Potratz, A. Ranft, C. Rössig, C. Rübe, R. Sauer, O. Schober, A. Schuck, B. Timmermann, F. Tirode, H. Van Den Berg, F. Van Valen, V. Vieth, N. Willich, W. Winkelmann, J. Whelan, R. B. Womer

Medicine and Health

Center for Radiotherapy Rheine-Osnabrueck
Universitätsklinikum Münster
Royal Victoria Infirmary
Institut Curie
Gustave Roussy Cancer Campus
Zentrum für Pathologie Kempten-Allgäu
University Hospital Schleswig-Holstein
University of Münster
Medical University of Vienna
Heinrich-Heine-University
Fred Hutchinson Cancer Research Center
Lunds University Hospital
Charles University in Prague
Christian-Albrechts-Universitat zu Kiel
Alder Hey Children’s NHS Foundation Trust
University Witten-Herdecke
Saarland University Medical Center
Friedrich-Alexander Universitat Erlangen-Nurnberg (FAU)
University Hospital of Essen
University of Amsterdam
University College London
University of Pennsylvania

Research output: Contribution to journal › Review article › peer-review

9 Scopus citations

Abstract

Curative therapies for Ewing sarcoma have been developed within cooperative groups. Consecutive clinical trials have systematically assessed the impact and timing of local therapy and the activity of cytotoxic drugs and their combinations. They have led to an increase of long-term disease-free survival to around 70% in patients with localized disease. Translational research in ES remains an area in which interdisciplinary and international cooperation is essential for future progress. This article reviews current state-of-the art therapy, with a focus on trials performed in Europe, and summarizes novel strategies to further advance both the cure rates and quality of survival.

Original language	English
Pages (from-to)	108-115
Number of pages	8
Journal	Klinische Padiatrie
Volume	227
Issue number	3
DOIs	https://doi.org/10.1055/s-0035-1545263
State	Published - 22 May 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being
SDG 17 Partnerships for the Goals

Keywords

Ewing sarcoma
chemotherapy
clinical trials
cooperative groups

Access to Document

10.1055/s-0035-1545263

Cite this

Bölling, T., Braun-Munzinger, G., Burdach, S., Calaminus, G., Craft, A., Delattre, O., Deley, M. C. L., Dirksen, U., Dockhorn-Dworniczak, B., Dunst, J., Engel, S., Faldum, A., Fröhlich, B., Gadner, H., Göbel, U., Gosheger, G., Hardes, J., Hawkins, D. S., Hjorth, L., ... Womer, R. B. (2015). Development of curative therapies for ewing sarcomas by interdisciplinary cooperative groups in Europe. Klinische Padiatrie, 227(3), 108-115. https://doi.org/10.1055/s-0035-1545263

@article{b1a42a63735e462190227b4fc213d451,

title = "Development of curative therapies for ewing sarcomas by interdisciplinary cooperative groups in Europe",

abstract = "Curative therapies for Ewing sarcoma have been developed within cooperative groups. Consecutive clinical trials have systematically assessed the impact and timing of local therapy and the activity of cytotoxic drugs and their combinations. They have led to an increase of long-term disease-free survival to around 70\% in patients with localized disease. Translational research in ES remains an area in which interdisciplinary and international cooperation is essential for future progress. This article reviews current state-of-the art therapy, with a focus on trials performed in Europe, and summarizes novel strategies to further advance both the cure rates and quality of survival.",

keywords = "Ewing sarcoma, chemotherapy, clinical trials, cooperative groups",

author = "T. B{\"o}lling and G. Braun-Munzinger and S. Burdach and G. Calaminus and A. Craft and O. Delattre and Deley, \{M. C.L.\} and U. Dirksen and B. Dockhorn-Dworniczak and J. Dunst and S. Engel and A. Faldum and B. Fr{\"o}hlich and H. Gadner and U. G{\"o}bel and G. Gosheger and J. Hardes and Hawkins, \{D. S.\} and L. Hjorth and C. Hoffmann and H. Kovar and J. Kruseova and R. Ladenstein and I. Leuschner and Lewis, \{I. J.\} and O. Oberlin and M. Paulussen and J. Potratz and A. Ranft and C. R{\"o}ssig and C. R{\"u}be and R. Sauer and O. Schober and A. Schuck and B. Timmermann and F. Tirode and \{Van Den Berg\}, H. and \{Van Valen\}, F. and V. Vieth and N. Willich and W. Winkelmann and J. Whelan and Womer, \{R. B.\}",

note = "Publisher Copyright: {\textcopyright} Georg Thieme Verlag KG Stuttgart • New York.",

year = "2015",

month = may,

day = "22",

doi = "10.1055/s-0035-1545263",

language = "English",

volume = "227",

pages = "108--115",

journal = "Klinische Padiatrie",

issn = "0300-8630",

publisher = "Georg Thieme Verlag",

number = "3",

}

Bölling, T, Braun-Munzinger, G, Burdach, S, Calaminus, G, Craft, A, Delattre, O, Deley, MCL, Dirksen, U, Dockhorn-Dworniczak, B, Dunst, J, Engel, S, Faldum, A, Fröhlich, B, Gadner, H, Göbel, U, Gosheger, G, Hardes, J, Hawkins, DS, Hjorth, L, Hoffmann, C, Kovar, H, Kruseova, J, Ladenstein, R, Leuschner, I, Lewis, IJ, Oberlin, O, Paulussen, M, Potratz, J, Ranft, A, Rössig, C, Rübe, C, Sauer, R, Schober, O, Schuck, A, Timmermann, B, Tirode, F, Van Den Berg, H, Van Valen, F, Vieth, V, Willich, N, Winkelmann, W, Whelan, J & Womer, RB 2015, 'Development of curative therapies for ewing sarcomas by interdisciplinary cooperative groups in Europe', Klinische Padiatrie, vol. 227, no. 3, pp. 108-115. https://doi.org/10.1055/s-0035-1545263

TY - JOUR

T1 - Development of curative therapies for ewing sarcomas by interdisciplinary cooperative groups in Europe

AU - Bölling, T.

AU - Braun-Munzinger, G.

AU - Burdach, S.

AU - Calaminus, G.

AU - Craft, A.

AU - Delattre, O.

AU - Deley, M. C.L.

AU - Dirksen, U.

AU - Dockhorn-Dworniczak, B.

AU - Dunst, J.

AU - Engel, S.

AU - Faldum, A.

AU - Fröhlich, B.

AU - Gadner, H.

AU - Göbel, U.

AU - Gosheger, G.

AU - Hardes, J.

AU - Hawkins, D. S.

AU - Hjorth, L.

AU - Hoffmann, C.

AU - Kovar, H.

AU - Kruseova, J.

AU - Ladenstein, R.

AU - Leuschner, I.

AU - Lewis, I. J.

AU - Oberlin, O.

AU - Paulussen, M.

AU - Potratz, J.

AU - Ranft, A.

AU - Rössig, C.

AU - Rübe, C.

AU - Sauer, R.

AU - Schober, O.

AU - Schuck, A.

AU - Timmermann, B.

AU - Tirode, F.

AU - Van Den Berg, H.

AU - Van Valen, F.

AU - Vieth, V.

AU - Willich, N.

AU - Winkelmann, W.

AU - Whelan, J.

AU - Womer, R. B.

PY - 2015/5/22

Y1 - 2015/5/22

N2 - Curative therapies for Ewing sarcoma have been developed within cooperative groups. Consecutive clinical trials have systematically assessed the impact and timing of local therapy and the activity of cytotoxic drugs and their combinations. They have led to an increase of long-term disease-free survival to around 70% in patients with localized disease. Translational research in ES remains an area in which interdisciplinary and international cooperation is essential for future progress. This article reviews current state-of-the art therapy, with a focus on trials performed in Europe, and summarizes novel strategies to further advance both the cure rates and quality of survival.

AB - Curative therapies for Ewing sarcoma have been developed within cooperative groups. Consecutive clinical trials have systematically assessed the impact and timing of local therapy and the activity of cytotoxic drugs and their combinations. They have led to an increase of long-term disease-free survival to around 70% in patients with localized disease. Translational research in ES remains an area in which interdisciplinary and international cooperation is essential for future progress. This article reviews current state-of-the art therapy, with a focus on trials performed in Europe, and summarizes novel strategies to further advance both the cure rates and quality of survival.

KW - Ewing sarcoma

KW - chemotherapy

KW - clinical trials

KW - cooperative groups

UR - https://www.scopus.com/pages/publications/84929575169

U2 - 10.1055/s-0035-1545263

DO - 10.1055/s-0035-1545263

M3 - Review article

C2 - 25985445

AN - SCOPUS:84929575169

SN - 0300-8630

VL - 227

SP - 108

EP - 115

JO - Klinische Padiatrie

JF - Klinische Padiatrie

IS - 3

ER -

Development of curative therapies for ewing sarcomas by interdisciplinary cooperative groups in Europe

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this